TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates

分组1 - TransMedics reported quarterly earnings of $0.70 per share, exceeding the Zacks Consensus Estimate of $0.29 per share, and showing an increase from $0.35 per share a year ago, resulting in an earnings surprise of 141.38% [1] - The company achieved revenues of $143.54 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 16.17%, compared to $96.85 million in the same quarter last year [2] - TransMedics has outperformed the S&P 500, with shares increasing approximately 53.7% since the beginning of the year, while the S&P 500 has declined by 4.3% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.38 on revenues of $133.93 million, and for the current fiscal year, it is $1.56 on revenues of $543.97 million [7] - The Medical - Instruments industry, to which TransMedics belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]